Centene Co. (NYSE:CNC) Director H James Dallas Purchases 1,693 Shares

Centene Co. (NYSE:CNC) Director H James Dallas purchased 1,693 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was bought at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the transaction, the director now directly owns 1,693 shares in the company, valued at $99,903.93. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Centene Stock Performance

Shares of NYSE:CNC opened at $57.81 on Wednesday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The company has a market cap of $29.18 billion, a price-to-earnings ratio of 10.04, a price-to-earnings-growth ratio of 0.78 and a beta of 0.46. Centene Co. has a 12 month low of $55.03 and a 12 month high of $81.42. The company has a 50-day moving average price of $61.51 and a 200-day moving average price of $68.41.

Institutional Investors Weigh In On Centene

Several institutional investors and hedge funds have recently bought and sold shares of CNC. Harris Associates L P lifted its holdings in Centene by 5.7% in the third quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock worth $1,980,932,000 after buying an additional 1,420,825 shares during the period. State Street Corp raised its holdings in Centene by 0.5% in the third quarter. State Street Corp now owns 23,468,159 shares of the company’s stock worth $1,766,683,000 after purchasing an additional 111,654 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Centene by 3.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock valued at $434,255,000 after buying an additional 194,566 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of Centene by 0.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,491,968 shares of the company’s stock worth $364,117,000 after buying an additional 25,595 shares during the period. Finally, Legal & General Group Plc lifted its position in Centene by 14.2% during the 2nd quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock valued at $339,042,000 after acquiring an additional 636,683 shares during the period. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analysts Set New Price Targets

CNC has been the topic of several recent analyst reports. Sanford C. Bernstein dropped their target price on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 30th. StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Wells Fargo & Company cut their price target on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Stephens decreased their price objective on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a report on Friday, December 13th. Finally, Jefferies Financial Group downgraded shares of Centene from a “hold” rating to an “underperform” rating and reduced their target price for the company from $68.00 to $52.00 in a research report on Tuesday, December 10th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $80.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.